Demographic and clinical characteristics are reported from an ongoing multistate randomized trial.
The Randomized Intervention for Children with Vesicoureteral Reflux is a carefully designed, randomized, placebo-controlled trial of antimicrobial prophylaxis for preventing recurrent urinary tract infection (UTI) in 607 children (91% girls) with grade II–IV VUR from 19 U.S. pediatric sites. The children were recruited after the first (91%) or second UTI in 2007 through May 2011 and were followed for 2 years.
Boys were significantly younger than girls (age <12 months, 84% vs. 46%); 32% of the 41 boys younger than 12 months were uncircumcised. Most children (80%) were white and 13% were Hispanic. Escherichia coli was the most common infective organism in first UTIs (89%), followed by Klebsiella pneumoniae (3%) and Proteus mirabilis (2%). Most…
Reviewing Author
DisclosuresGrant/Research SupportNIH Institutional Clinical and Translational Science Award; Agency for Healthcare Research and Quality National Center for Pediatric Practice Based Research Learning; Patient-Centered Outcomes Research Institute
Editorial BoardsCurrent Problems in Pediatric Adolescent Healthcare
Leadership Positions in Professional Societies College of Physicians of Philadelphia (Board of Trustees)
DisclosuresGrant/Research SupportNIH Institutional Clinical and Translational Science Award; Agency for Healthcare Research and Quality National Center for Pediatric Practice Based Research Learning; Patient-Centered Outcomes Research Institute
Editorial BoardsCurrent Problems in Pediatric Adolescent Healthcare
Leadership Positions in Professional Societies College of Physicians of Philadelphia (Board of Trustees)